"covid-19-vaccine"

The scientific head of the US operation to develop a vaccine, Moncef Slaoui said Monday that the green light would probably come in December.

Healthcare workers, people above 65 yrs will be given COVID vaccine on priority, says Union Health Minister

The team is also testing whether the vaccine stops people developing COVID-19 in larger Phase 3 trials and early results from this crucial stage are expected in the coming weeks.

Global drugmakers Pfizer and BioNTech said on Wednesday that their COVID-19 vaccine was found 95 per cent effective in the final analysis of the Phase 3 trial.

Pfizer said the vaccine had no serious side effects and that the company will apply for emergency use authorization from US regulators "within days"

Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.

Moderna, whose results stem from a clinical trial of more than 30,000 participants, expects to have approximately 20 million doses ready to ship in the United States by year-end.

BE is making the vaccine in collaboration with Dynavax Technologies Corporation (Dynavax), a US-based vaccine focused biopharmaceutical company, and Baylor College of Medicine, a health sciences university in Houston.

The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR

Regulatory approval was being sought for the vaccine to progress to Phase 3 clinical trials before the end of the year.

SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.

Hyderabad: Hyderabad Management Association (HMA) has launched a nation-wide survey aimed at learning more about public’s understanding of Covid-19 disease and Covid vaccine. With the internet full of claims about possible repercussions to the upcoming Covid vaccine, the HMA has launched the survey to know what the public would do in the wake of this […]

Hyderabad: The Covid-19 vaccine development is happening at a much faster pace when compared to other vaccines and it is pushing the innovation and manufacturing capabilities of developed and developing countries. Speaking at the 28th Annual Hysea Innovation Summit, Bharat Biotech MD Dr Krishna Ella said that the pandemic vaccine coming out in 12 months […]

Given our vast population, distributing vaccine effectively is an elephantine task

Formed to have an effective vaccination mechanism, these groups will oversee and coordinate administration of the vaccine

Collaboration will allow Dr Reddy’s to identify and use some of the Biotechnology Industry Research Assistance Council’s clinical trial centres

The coronavirus dominated the opening minutes of the Trump-Biden face-off with President Trump terming the contagion a “worldwide problem”.

Union Finance Minister and BJP leader Nirmala Sitharaman released the party's manifesto.

The World Health Organisation (WHO) has identified 42 candidate vaccines in clinical trials, ten of which are in the most advanced "phase 3" stage.

The PM emphasized that the government is working on a blueprint to make the Covid-19 vaccine, when it is ready, available to each and every citizen.